{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:00:03Z","timestamp":1785214803529,"version":"3.55.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2024-00410513"],"award-info":[{"award-number":["RS-2024-00410513"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>\n                    Platinum-based chemotherapy remains a key treatment for advanced non-small cell lung cancer (NSCLC) in patients without actionable mutations or response to immunotherapy. Emerging evidence highlights the gut\u2013lung axis as an important factor influencing lung cancer biology and treatment outcomes. Fecal microbiota transplantation (FMT) may restore gut microbial balance and improve anticancer therapy response. However, evidence in patients receiving conventional chemotherapy is limited. We report a case of FMT used to treat refractory\n                    <jats:italic>Clostridioides difficile<\/jats:italic>\n                    infection (CDI) in a patient with advanced NSCLC and evaluate its effects on gut microbial reconstitution and clinical response to chemotherapy. A 64-year-old woman with heavily pretreated NSCLC developed recurrent CDI during eighth-line chemotherapy (etoposide and carboplatin). After failure of standard antibiotic therapy, she underwent colonoscopic FMT. Gut microbiota shifts were analyzed using 16S rRNA long-read sequencing (V1\u2013V10), with taxonomic assignment based on the NCBI 16S database. Following FMT, diarrheal symptoms resolved, and the patient completed the subsequent chemotherapy cycle. Follow-up chest computed tomography showed radiologic improvement, with a reduction in the linear extent of consolidation from 91.4 to 76.7\u00a0mm. Microbiological analysis revealed a shift toward gut homeostasis, including increased abundance of\n                    <jats:italic>Bacillota<\/jats:italic>\n                    (formerly Firmicutes), enrichment of\n                    <jats:italic>Bifidobacterium breve<\/jats:italic>\n                    , and depletion of\n                    <jats:italic>Klebsiella pneumoniae.<\/jats:italic>\n                    This case suggests that FMT effectively treats refractory CDI in patients with advanced cancer and may support the efficacy of conventional cytotoxic chemotherapy by modulating the immunometabolic milieu through the gut\u2013lung axis.\n                  <\/jats:p>","DOI":"10.3389\/fonc.2026.1876788","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:26:02Z","timestamp":1785212762000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Fecal microbiota transplantation resensitizes advanced non-small cell lung cancer to platinum-based chemotherapy"],"prefix":"10.3389","volume":"16","author":[{"given":"Yun Joon","family":"Lee","sequence":"first","affiliation":[{"name":"College of Medicine, Inha University","place":["Incheon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hwan","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Inha University College of Medicine, Inha University Hospital","place":["Incheon, Republic of Korea"]},{"name":"Department of Hospital Medicine, Inha University College of Medicine, Inha University Hospital","place":["Incheon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boram","family":"Cha","sequence":"additional","affiliation":[{"name":"Department of Hospital Medicine, Inha University College of Medicine, Inha University Hospital","place":["Incheon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongbeom","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Hospital Medicine, Inha University College of Medicine, Inha University Hospital","place":["Incheon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kye-Sook","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Hospital Medicine, Inha University College of Medicine, Inha University Hospital","place":["Incheon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Woon","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Hospital Medicine, Inha University College of Medicine, Inha University Hospital","place":["Incheon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Hee","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Radiology, Inha University School of Medicine, Inha University Hospital","place":["Incheon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Hyeok","family":"Lim","sequence":"additional","affiliation":[{"name":"Division of Pulmonology, Department of Internal Medicine, Inha University College of Medicine, Inha University Hospital","place":["Incheon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1177\/1753465815617871","article-title":"Management of advanced non-small cell lung cancers with known mutations or rearrangements: Latest evidence and treatment approaches","volume":"10","author":"Shea","year":"2016","journal-title":"Ther Adv Respir Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-019-0160-6","article-title":"Microbes, metabolites, and the gut-lung axis","volume":"12","author":"Dang","year":"2019","journal-title":"Mucosal Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217096","article-title":"Gut microbial metabolites in lung cancer development and immunotherapy: Novel insights into gut-lung axis","volume":"598","author":"Li","year":"2024","journal-title":"Cancer Lett"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2025.103025","article-title":"Fecal microbiota transplantation to enhance cancer treatment outcomes across different cancer types: A systematic literature review","volume":"140","author":"Wekking","year":"2025","journal-title":"Cancer Treat Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet J"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3869","article-title":"Dada2: High-resolution sample inference from Illumina amplicon data","volume":"13","author":"Callahan","year":"2016","journal-title":"Nat Methods"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1128\/aem.00062-07","article-title":"Na\u00efve Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy","volume":"73","author":"Wang","year":"2007","journal-title":"Appl Environ Microbiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009490","article-title":"Fasttree 2\u2013approximately maximum-likelihood trees for large alignments","volume":"5","author":"Price","year":"2010","journal-title":"PloS One"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/mst010","article-title":"Mafft multiple sequence alignment software version 7: Improvements in performance and usability","volume":"30","author":"Katoh","year":"2013","journal-title":"Mol Biol Evol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.08.006","article-title":"Microbiome and cancer","volume":"39","author":"Cullin","year":"2021","journal-title":"Cancer Cell"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.28779","article-title":"Mechanism of anticancer action of Bifidobacterium: Insights from gut microbiota","volume":"16","author":"Do","year":"2025","journal-title":"Oncotarget"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/science.1240527","article-title":"Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment","volume":"342","author":"Iida","year":"2013","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1868122","article-title":"Oral administration of Bifidobacterium breve promotes antitumor efficacy via dendritic cells-derived interleukin 12","volume":"10","author":"Li","year":"2021","journal-title":"Oncoimmunology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12935-025-04099-w","article-title":"Bifidobacterium enhances the antitumor efficacy of carboplatin in glioblastoma cells: Targeting apoptotic and cell cycle regulatory pathways via caspase, AKT\/PTEN, and P53\/P21 signaling","volume":"26","author":"Asoudeh-Fard","year":"2025","journal-title":"Cancer Cell Int"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.196.Supp.143.12","article-title":"Killed Klebsiella pneumoniae treatment reduces tumor burden in murine melanoma","volume":"196","author":"Costa","year":"2016","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27041905","article-title":"The dynamic gut microbiota: Monitoring alterations during lung cancer progression for diagnosis and precision medicine","volume":"27","author":"Xiao","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.cmet.2021.03.002","article-title":"Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity","volume":"33","author":"He","year":"2021","journal-title":"Cell Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-14-3128","article-title":"CCR 20th anniversary commentary: Immune-related response criteria\u2014capturing clinical activity in immuno-oncology","volume":"21","author":"Hoos","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20170457","article-title":"Immune-related tumour response assessment criteria: A comprehensive review","volume":"91","author":"Somarouthu","year":"2018","journal-title":"Br J Radiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2010.10.017","article-title":"Prevalence and effectiveness of first-, second-, and third-line systemic therapy in a cohort of unselected patients with advanced non-small cell lung cancer","volume":"73","author":"Zietemann","year":"2011","journal-title":"Lung Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2393270","article-title":"The interplay between gut microbiota, short-chain fatty acids, and implications for host health and disease","volume":"16","author":"Hays","year":"2024","journal-title":"Gut Microbes"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy936","article-title":"Gastrointestinal microbiota disruption and risk of colonization with carbapenem-resistant Pseudomonas aeruginosa in intensive care unit patients","volume":"69","author":"Pettigrew","year":"2019","journal-title":"Clin Infect Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1038\/s41598-021-85946-4","article-title":"Third generation cephalosporins and piperacillin\/tazobactam have distinct impacts on the microbiota of critically ill patients","volume":"11","author":"Gamage","year":"2021","journal-title":"Sci Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2045696","article-title":"Targeting coagulation to unlock antitumor immunity","volume":"11","author":"Galmiche","year":"2022","journal-title":"Oncoimmunology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00262-025-04227-5","article-title":"Efficacy and safety of low-molecular-weight heparin or rivaroxaban combined with immunotherapy and chemotherapy in the treatment of advanced nonsmall cell lung cancer: A prospective, randomized, controlled clinical study","volume":"74","author":"Zhang","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"B28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12865-025-00710-x","article-title":"Fecal microbiota transplantation enhanced the effect of chemoimmunotherapy by restoring intestinal microbiota in LLC tumor-bearing mice","volume":"26","author":"Wang","year":"2025","journal-title":"BMC Immunol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1876788\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:26:03Z","timestamp":1785212763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1876788\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":28,"alternative-id":["10.3389\/fonc.2026.1876788"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1876788","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"article-number":"1876788"}}